A5046343290- Lipoproteins and Cardiovascular Health
- Heart Failure Treatment and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Chronic Disease Management Strategies
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Cardiac, Anesthesia and Surgical Outcomes
- Venous Thromboembolism Diagnosis and Management
- Cardiac Fibrosis and Remodeling
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
- Health, psychology, and well-being
- Blood Pressure and Hypertension Studies
- Health Promotion and Cardiovascular Prevention
Tbilisi State Medical University
2024-2025
Tbilisi State University
2024
University of Georgia
2024
Background. For preventive interventions in general practice to succeed, patients' points of view must be taken into account addition those GPs. Objective. To explore views and beliefs about the importance lifestyle interventions, assess their readiness make changes willingness receive support from Methods. Cross-sectional survey conducted by EUROPREV primary care practices 22 European countries. Patients were consecutively selected interviewed September 2008 2009. Results. Seven thousand...
Abstract Background In re-perfused non ST-segment-elevation myocardial infarction, inflammation is a major contributor to damage. One of these medicines colchicine, well-known medication that has been used in clinical practice for millennia treat inflammation. Indeed, colchicine direct anti-inflammatory and pleiotropic effects, as well possible anti-arrhythmic, anti-fibrotic anti-atherosclerotic properties all which are very relevant this population. Colchicine effects the context acute...
Background: Soluble suppression of tumorigenicity 2 (sST2) belongs to the interleiukin-1 receptor family and has been found be elevated in different cardiovascular conditions(1, 2). However, its utility predicting severity diseases or mortality outcomes a topic debate. This study explores relationship between soluble ST2 prognosis heart failure patients with reduced ejection fraction.Methods: The involved measuring sSt2 at baseline (N= 111), 1 month 12 months EF. Patients chronic enrolled...